Lars Henning Engelholm

Lars Henning Engelholm

ORCID: 0000-0002-6616-1232

Publication year:
All
1 - 10 out of 67Page size: 10
  1. 2024
  2. Published

    Antibody–Drug Conjugates: The Dynamic Evolution from Conventional to Next-Generation Constructs

    Metrangolo, Virginia & Engelholm, Lars Henning, 2024, In: Cancers. 16, 2, 20 p., 447.

    Research output: Contribution to journal › Review › Research › peer-review

  3. 2023
  4. Published

    A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids

    Senkowski, W., Gall-Mas, L., Falco, M. M., Li, Y., Lavikka, K., Kriegbaum, M. C., Oikkonen, J., Bulanova, D., Pietras, E. J., Voßgröne, K., Chen, Y. J., Erkan, E. P., Dai, J., Lundgren, A., Grønning Høg, M. K., Larsen, I. M., Lamminen, T., Kaipio, K., Huvila, J., Virtanen, A. & 9 others, Engelholm, Lars Henning, Christiansen, P., Santoni Rugiu, Eric, Huhtinen, K., Carpén, O., Hynninen, J., Hautaniemi, S., Vähärautio, A. & Wennerberg, Krister, 2023, In: Developmental Cell. 58, 12, p. 1106-1121.e7 24 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Targeted delivery of alcohol-containing payloads with antibody-drug conjugates

    Grier, K. E., Hansen, A. H., Haxvig, C. S., Li, Xin, Krigslund, O., Behrendt, Niels, Engelholm, Lars Henning, Rossi, F., Sousa, B. C., Harradence, G. J., Camper, N. & Qvortrup, K. M., 2023, In: Chemical Communications. 59, 47, p. 7240-7242

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. 2022
  7. Published

    Hypomorphic expression of parathyroid Bmal1 disrupts the internal parathyroid circadian clock and increases parathyroid cell proliferation in response to uremia

    Egstrand, S., Mace, M. L., Morevati, M., Nordholm, A., Engelholm, Lars Henning, Thomsen, J. S., Brüel, A., Naveh-Many, T., Guo, Y., Ølgaard, Klaus & Lewin, E., Jun 2022, In: Kidney International. 101, 6, p. 1232-1250 19 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment

    Fjæstad, K. Y., Rømer, A. M. A., Goitea, V., Johansen, A. Z., Thorseth, M. L., Carretta, M., Engelholm, Lars Henning, Grøntved, L., Junker, N. & Madsen, Daniel Hargbøl, 2022, In: Oncogene. 41, p. 1364-1375

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    The endocytic receptor uPARAP is a regulator of extracellular thrombospondin-1

    Nørregaard, Kirstine Sandal, Jürgensen, Henrik Jessen, Ingvarsen, S. Z., Heltberg, S. S., Hagensen, C. E., Gårdsvoll, Henrik, Madsen, D. H., Jensen, O. N., Engelholm, Lars Henning & Behrendt, Niels, 2022, In: Matrix Biology. 111, p. 307-328 22 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Uncovering mediators of collagen degradation in the tumor microenvironment

    Thorseth, M. L., Carretta, M., Jensen, C., Mølgaard, K., Jürgensen, Henrik Jessen, Engelholm, Lars Henning, Behrendt, Niels, Willumsen, N. & Madsen, Daniel Hargbøl, 2022, In: Matrix Biology Plus. 13, 100101.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. 2021
  12. Published

    Osteosarcoma and metastasis associated bone degradation—a tale of osteoclast and malignant cell cooperativity

    Nørregaard, Kirstine Sandal, Jürgensen, Henrik Jessen, Gårdsvoll, Henrik, Engelholm, Lars Henning, Behrendt, Niels & Søe, K., 2021, In: International Journal of Molecular Sciences. 22, 13, 6865.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    The Collagen Receptor uPARAP in Malignant Mesothelioma: A Potential Diagnostic Marker and Therapeutic Target

    Cakilkaya, Pinar, Sørensen, R. R., Jürgensen, Henrik Jessen, Krigslund, O., Gårdsvoll, Henrik, Nielsen, C. F., Santoni Rugiu, Eric, Behrendt, Niels & Engelholm, Lars Henning, 2021, In: International Journal of Molecular Sciences. 22, 21, 17 p., 11452.

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. Published

    The Urokinase Receptor (uPAR) as a “Trojan Horse” in Targeted Cancer Therapy: Challenges and Opportunities

    Metrangolo, Virginia, Ploug, Michael & Engelholm, Lars Henning, 2021, In: Cancers. 13, 21, 45 p., 5376.

    Research output: Contribution to journal › Review › Research › peer-review

Previous 1 2 3 4 5 6 7 Next

ID: 9647887